Hyun-Soo Kim
Vorstandsvorsitzender bei PHARMICELL CO., LTD.
Vermögen: 28 Mio $ am 30.04.2024
Profil
Hyun-Soo Kim is currently the Chief Executive Officer and Director at Pharmicell Co., Ltd.
He previously worked as Co-CEO, Director, Head-Research & Development at FCB Twelve Co., Ltd.
from 2009 to 2011, and as Chief Executive Officer & Director at FCB-Pharmicell Co., Ltd.
from 2010 to 2011.
He completed his undergraduate degree at Yonsei University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PHARMICELL CO., LTD
10,89% | 29.02.2024 | 6 535 247 ( 10,89% ) | 28 Mio $ | 30.04.2024 |
Aktive Positionen von Hyun-Soo Kim
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMICELL CO., LTD. | Vorstandsvorsitzender | 19.08.2009 |
Ehemalige bekannte Positionen von Hyun-Soo Kim
| Unternehmen | Position | Ende |
|---|---|---|
FCB Twelve Co., Ltd.
 FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables FCB Twelve Co., Ltd. is engaged in manufacturing, distributing, and selling cell therapeutic drugs and apparels. It operates in two segments: Biotechnology and Fashion. The Biotechnology Segment offers stem cell therapeutic drugs, adult stem cell banking service, and stem cell skin care solution. The Fashion Segment offers garments and other fashion accessories under three brands such as basic by GV2, studio yume, and le body lingerie. It also provides hospital management consulting, resort amenities and services, as well as technology transfer. The company was founded on August 20, 1968 and is headquartered in Seoul, South Korea. | Präsident | 06.10.2011 |
FCB-Pharmicell Co., Ltd.
 FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services FCB-Pharmicell Co., Ltd. develops adult cell stem therapy. It also provides testing services for cell drugs. It has an operating centre in Europe. The company was founded by Kim Hyoo-soo and is headquartered in Seongnam, Korea. | Präsident | 27.06.2011 |
Ausbildung von Hyun-Soo Kim
| Yonsei University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHARMICELL CO., LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
FCB-Pharmicell Co., Ltd.
FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services FCB-Pharmicell Co., Ltd. develops adult cell stem therapy. It also provides testing services for cell drugs. It has an operating centre in Europe. The company was founded by Kim Hyoo-soo and is headquartered in Seongnam, Korea. | Commercial Services |
FCB Twelve Co., Ltd.
FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables FCB Twelve Co., Ltd. is engaged in manufacturing, distributing, and selling cell therapeutic drugs and apparels. It operates in two segments: Biotechnology and Fashion. The Biotechnology Segment offers stem cell therapeutic drugs, adult stem cell banking service, and stem cell skin care solution. The Fashion Segment offers garments and other fashion accessories under three brands such as basic by GV2, studio yume, and le body lingerie. It also provides hospital management consulting, resort amenities and services, as well as technology transfer. The company was founded on August 20, 1968 and is headquartered in Seoul, South Korea. | Consumer Non-Durables |
